BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Bargains & Bubbles

Goldman Sachs Is Earning Like It’s 2021. The Market Is Pricing It Like Something Better.

Moe Alsumidaie, MBA, MSF by Moe Alsumidaie, MBA, MSF
August 20, 2026
in Bargains & Bubbles
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

Goldman Sachs spent most of the last decade trading below the value of its own assets. After the 2008 crisis, when the firm famously converted from an investment bank to a bank holding company to access Federal Reserve funding, the market spent years treating it as a relic of a wilder era, worth less than the sum of its parts. The consumer banking detour, the Marcus experiment that burned through billions and then quietly retreated, did not help. For a long stretch, owning Goldman stock meant believing the firm would eventually be allowed to be Goldman again.

That moment appears to have arrived. The numbers filed this summer are, by any honest reading, extraordinary. The tension is that the market has noticed, and then some.

The quick read

The 10-Q filed August 3, 2026 shows Goldman earning at a pace it has not sustained since its 2021 peak, with a return on equity that most banks would frame and hang on the wall. The stock, at roughly $1,022, sits at a price-to-earnings multiple in the 88th percentile of its own decade-long history, our data show. The math says the business is performing; the mood, meaning what the market is currently willing to pay per dollar of profit, says the performance will not only continue but expand. Those two readings can coexist, but only if the deal-making boom that drove this quarter is not a one-time event.

A Quarter That Demands an Explanation

The simplest way to describe the second quarter ended June 30, 2026: Goldman nearly doubled its profit versus the same quarter a year earlier. Net revenues reached $20.34 billion, up from $14.58 billion in Q2 2025, and net income followed at a comparable pace. Think of it this way: for every dollar the firm earned in that quarter last year, it earned nearly two this year. That is not a rounding error or an accounting quirk. Something structural shifted.

BullScope TerminalGoldman Sachs was the article. The engine is the product.Same yardsticks, any ticker: filed financials in, math-vs-mood out. Nothing here is advice; it is the evidence, organized.Run another company →

The engine was Global Banking and Markets, the division that houses trading desks and deal advisory. It generated more than half of total firm revenue for the quarter, a dramatic jump year-over-year, driven by what the Q2 2026 earnings call described as record revenues in both equities and fixed-income trading, alongside investment banking fees at their highest level since 2021. Large-cap corporate mergers and acquisitions surged by volume in the first half of 2026, with Goldman leading more than a trillion dollars in announced deals. That last figure is worth sitting with: more deal value than most countries produce in a year, flowing through one firm’s advisory business in six months.

For anyone who watched Goldman limp through 2022 and 2023, when investment banking fees collapsed and the firm was still digesting its consumer lending losses, this quarter reads like a different company. It is, in some ways, the same firm that posted a full-year 2025 EPS of $51.32, itself a near-record, now accelerating further.

What the Filed Numbers Actually Show

Return on equity, the ratio of profit to the shareholders’ money funding the business, is the metric Goldman’s own management uses to judge itself. An ROE of 10% means the firm earns ten cents for every dollar of equity. Goldman’s annualized Q2 2026 ROE of 23.5% is nearly double its pace from the same quarter a year earlier. For context, most large banks consider anything above 15% a strong result. Goldman is running well above that bar.

Book value per common share, which is the accounting value of what each share owns in the business after all debts, stood at $367.67 as of June 30, 2026. The stock trades near $1,022. That means the market is paying roughly three times what the accountants say each share is worth in hard assets. On tangible book value, which strips out intangible items and gives a more conservative floor, the ratio sits at about 2.97. Historically, Goldman has traded much closer to book during periods of uncertainty. The current premium reflects confidence that the firm will keep earning well above its cost of capital for years, not quarters.

The capital return picture adds another layer. Goldman declared a quarterly dividend of $5.00 per share in July 2026, up from the prior $4.50, while also conducting substantial share buybacks during the quarter. Together, that is more capital returned to shareholders in three months than many financial firms earn in a year. The firm’s CET1 ratio, a regulatory measure of financial cushion where higher means safer, held comfortably above regulatory minimums, suggesting the firm is not stretching to fund these returns.

BullScope TerminalWant the full evidence sheet behind pieces like this?The terminal runs the complete workup: Goldman Sachs and 500+ other names, on the same official data.See the evidence engine →

Where the Crowd Has Gathered

The stock is up nearly 40% over the past twelve months, our data show, and sits about 11% below its 52-week high. The trailing price-to-earnings ratio of 17.8 sits at the 88th percentile of Goldman’s own decade-long range, against a decade median of 11.8. That gap is the math-versus-mood tension in plain arithmetic: the business is priced as if the current earnings pace is not a peak but a new floor.

Analyst opinion is broadly supportive but not unanimous. Wells Fargo analyst Mike Mayo raised his valuation estimate to $1,325 on July 15, 2026, maintaining an Overweight rating, and Barclays analyst Jason Goldberg moved his estimate meaningfully higher on the same date. UBS analyst Erika Najarian, by contrast, maintained a neutral stance on August 3, 2026, raising her valuation estimate modestly to $1,150 while describing a “modestly higher valuation outlook” without conviction. HSBC’s Saul Martinez upgraded from Reduce to a neutral stance on July 21, 2026, a move that signals less pessimism rather than enthusiasm. The range of valuation estimates across more than twenty analysts per Zacks data as of August 19, 2026 reflects genuine disagreement about whether this quarter’s results are repeatable.

The honest uncertainty is this: Goldman’s trading and deal-making revenues are, by nature, volatile. The 2021 earnings peak was followed by a collapse and then a trough. The current boom is real and filed. Whether it persists depends on M&A volumes, market volatility, and the AI-driven investment cycle that Goldman executives cited on the earnings call as a structural tailwind. None of those factors are in the 10-Q. They are bets on the future, and the current price embeds a fairly optimistic version of that future.

Reading the numbers

  • Net revenue, Q2 2026: $20.34 billion. What it is: total income before expenses, from the 10-Q for the quarter ended June 30, 2026. What it means here: this is the highest single-quarter revenue Goldman has reported in recent history, nearly 40% above the same quarter last year. Everyday version: if a neighborhood bakery normally sold $14,000 worth of bread in a quarter and suddenly sold $20,000, the owner would want to know whether the block got more foot traffic permanently or just had a festival.
  • Annualized ROE, Q2 2026: 23.5%. What it is: return on equity, the profit the firm generates for every dollar shareholders have put in, annualized from one quarter. What it means here: Goldman is earning nearly a quarter of its equity base in a single year, roughly double its Q2 2025 pace. Everyday version: a household with $100,000 in savings earning 23.5% would collect $23,500 in a year; at last year’s 12.8% pace, they’d have collected $12,800.
  • P/E ratio: 17.8, versus decade median of 11.8. What it is: price-to-earnings, the price tag per dollar of annual profit, our data computed from filed EPS and current market price. What it means here: the market is paying 51% more per dollar of Goldman’s earnings than it has on a typical year over the past decade. Everyday version: a coffee shop that normally sells for 12 times its annual profit is now being offered at 18 times, because buyers expect profits to keep rising fast.
  • Book value per share: $367.67; stock price: ~$1,022. What it is: book value is the accounting net worth per share from the June 30, 2026 10-Q; the stock price is the market’s current bid. What it means here: the market pays nearly three times the accountants’ valuation of each share. Everyday version: a house appraised at $368,000 selling for $1,022,000 means the buyer is paying for the neighborhood’s future, not just the building today.
  • FY2025 EPS: $51.32, from the 10-K for fiscal year ended December 31, 2025. What it is: diluted earnings per share for the full year. What it means here: the 2025 full year was already near the 2021 record of $59.45 EPS, and Q2 2026 alone ran at an annualized pace above that. Everyday version: a worker who had their best salary year ever in 2025 is now on track for an even bigger paycheck in 2026.

If earnings continue near the filed 2025-to-2026 trend, our data show the decade-median multiple of 11.8 would imply a price well below today’s level, while a multiple in the upper quartile of the historical range would sit closer to current prices. The condition that matters is whether deal volumes and trading revenues hold. That question is open, and the filed numbers cannot answer it.

Sources

  • Goldman Sachs 10-Q, quarter ended June 30, 2026 (SEC EDGAR)
  • Goldman Sachs 10-K, fiscal year ended December 31, 2025 (SEC EDGAR)
  • Goldman Sachs Q2 2026 Earnings Press Release
  • Goldman Sachs Q2 2025 Earnings Press Release
  • Goldman Sachs Q2 2026 Earnings Call Transcript (The Motley Fool)
  • Goldman Sachs Price-to-Tangible-Book (GuruFocus)
  • Goldman Sachs Analyst Valuation Estimates (Zacks, August 19, 2026)
  • Goldman Sachs Analyst Ratings Roundup (Barchart)
  • Goldman Sachs Dividend History (StockEvents)
  • Goldman Sachs 2008 Bank Holding Company Conversion (Goldman Sachs)
BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read Goldman Sachs’ filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.

Recommended For You

Halozyme: The Royalty Machine Trading at a Premium to Its Own History

by Moe Alsumidaie, MBA, MSF
September 9, 2026
0

Six years ago, Halozyme Therapeutics was a mid-sized biotech with a clever idea and a thin income statement. The idea was ENHANZE, a drug-delivery technology that dissolves the...

Read moreDetails

Merck Is Printing Money and Losing Money at the Same Time. Both Are True.

by Moe Alsumidaie, MBA, MSF
September 7, 2026
0

A trailing price-to-earnings ratio of 120 sits next to a price-to-sales ratio near its highest point in a decade. Those two numbers describe the same stock on the...

Read moreDetails

A $2.4 Billion Question: What Sarepta’s Filed Numbers Actually Say

by Moe Alsumidaie, MBA, MSF
September 3, 2026
0

The gist of it Sarepta's filed numbers tell a story of a company that briefly turned profitable in 2024, then swung back to a loss in 2025 after...

Read moreDetails

The Quiet Compounder at a Loud Price: What Royalty Pharma’s Filings Actually Say

by Moe Alsumidaie, MBA, MSF
September 2, 2026
0

Royalty Pharma's stock sat at an all-time low in December 2024. By late August 2026, it had touched an all-time high above $62. That is a gain of...

Read moreDetails

Half the Price, Same Business: What Zoetis’s Filed Numbers Actually Say

by Moe Alsumidaie, MBA, MSF
August 31, 2026
0

Two years ago, Zoetis traded at roughly 35 times its annual earnings. Today it trades at roughly 12 times. The revenue line has kept growing. The margin line...

Read moreDetails
Next Post

Lowe's Narrows the Range: What the Call Revealed That the Filing Couldn't Hide

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Lowe’s Narrows the Range: What the Call Revealed That the Filing Couldn’t Hide

August 20, 2026

Evidence Sheet: Bank Of America Corp /de/ (BAC)

August 14, 2026

Evidence Sheet: Home Depot (HD)

August 27, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.